They found suppressed IFN-α expression, via decreased mechanistic target of rapamycin (mTOR)1 signaling, in patients with T2D using metformin, which probably reduced selection intensity of germinal centers and affinity maturation of immune cells [25]. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.